Abbott diet drug study renews calls for U.S. ban (Reuters)
Topic: Med News|Abbott diet drug study renews calls for U.S. ban (Reuters)
Reuters - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.
No Comments »

Links in Technorati
Add to del.icio.us
Subscribe to RSS
